MoneyWorks4Me

Lasa Supergenerics to raise funds up to Rs 100 crore

08 Jan 2018 Evaluate

Lasa Supergenerics has received an approval for raising funds  up to extent of Rs 100 crore by way of offer, issue and allotment of equity shares to the existing shareholders of the company on rights basis (Right Issue). The Board of Directors of the company in its meeting held on January 06, 2018, approved the same.

Lasa Supergenerics manufactures and distributes chemicals. The company offers veterinary API products, animal feed ingredients, and reagents for therapeutic uses.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..